Richard McHale - ResMed Insider

  President
Mr. Richard McHale is President Respiratory Care of the Company. He previously served as the companys chief human resources officer, beginning in November 2013, and joined ResMed in 2011 as director of its United Kingdom business team. Mr. McHale has 25 years experience in the life sciences sector, working primarily in commercial roles within pharmaceutical, biotechnology and medical technology companies. Prior to joining ResMed, he was managing director of UCB Pharmas United Kingdom and Ireland business units. He also served as chair of the European Medicines Group and a member of the Board of Management for the Association of British Pharmaceutical Industry
Age: 52  President Since 2017      
858-836-5000  http://www.resmed.com
McHale holds a master?s degree in coaching psychology from the Metanoia Institute in London.

Richard McHale Latest Insider Activity

Management Efficiency

The company has Return on Asset of 10.72 % which means that on every $100 spent on asset it made $10.72 of profit. This is considered to be average in the sector. In the same way, it shows return on shareholders equity (ROE) of 15.7 % implying that it generated $15.7 on every 100 dollars invested.
The company has 281.45 M in debt with debt to equity (D/E) ratio of 13.6 . This implies that the company may be unable to create cash to meet all of its financial commitments. ResMed has Current Ratio of 2.05 demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due.

Similar Executives

Showing few of many executives

PRESIDENT Since

William McDowellCigna Corporation
2015
Jonathan FriedmanDENTSPLY SIRONA
2016
Dominique GrauAgilent Technologies
2014
Henrik AncherJensenAgilent Technologies
2013
Edwin DetrickCigna Corporation
N/A
ALAN MUNEYCigna Corporation
2017
Scott BruderStryker Corporation
2013
Greg AllenCigna Corporation
2015
Albert SterkenburgDENTSPLY SIRONA
2009
FinkStryker Corporation
2016
Michael TangAgilent Technologies
2016
Michael PhillipsCigna Corporation
2014
Herbert FritchCigna Corporation
2012
Brain EvankoCigna Corporation
2017
Nicholas AlexosDENTSPLY SIRONA
2017
Graham McleanStryker Corporation
2017
Samraat RahaAgilent Technologies
2017
Karen BoylanTeleflex Incorporated
2014
Alicia RodriguezAgilent Technologies
N/A
Liam KellyTeleflex Incorporated
2018
Lisa BacusCigna Corporation
2017

Entity Summary

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications that diagnose, treat, and manage respiratory disorders comprising sleep disordered breathing, chronic obstructive pulmonary disease, neuromuscular disease, and other chronic diseases. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California. ResMed operates under Medical Instruments Supplies classification in USA and is traded on New York Stock Exchange. It employs 5940 people.ResMed (RMD) is traded on New York Stock Exchange in USA. It is located in 9001 Spectrum Center Boulevard and employs 5,940 people.

ResMed Leadership Team

John Wareham, Independent Director
Ronald Taylor, Lead Independent Director
Rob Douglas, President COO
Christopher Roberts, Independent Director
Gary Pace, Independent Director
Chris Roberts, Independent Director
Robert Douglas, Pres and COO
Agnes Lee, Senior Director - Investor Relations
Carol Burt, Independent Director
Rich Sulpizio, Independent Director
Peter Farrell, Non-Executive Chairman of the Board
Jim Hollingshead, President - Americas
Brett Sandercock, CFO and Principal Accounting Officer
Ron Taylor, Lead Independent Director
Don Darkin, President - Sleep-disordered Breathing Strategic Business Unit
Jack Wareham, Independent Director
Anne Reiser, President Europe
Karen Drexler, Director
Raj Sodhi, President ? Software as a Service (SaaS) Business and CTO
David Pendarvis, Chief Admin. Officer, Global General Counsel and Secretary
Richard Sulpizio, Independent Director
Michael Farrell, CEO and Director
Richard McHale, President ? Respiratory Care
Donald Darkin, President ? innovation & operations

Stock Performance Indicators

Current Sentiment - RMD

ResMed Investor Sentiment

Greater number of Macroaxis users are at this time bullish on ResMed. What is your perspective on investing in ResMed? Are you bullish or bearish?
Bullish
Bearish
50% Bullish
50% Bearish
Skip
Currently Active Assets on Macroaxis
S   
Purchased over 400 shares of
few hours ago
Traded for 6.28
VTVT   
Purchased over 100 shares of
few hours ago
Traded for 2.92
GM   
Purchased over 90 shares of
few hours ago
Traded for 32.12
VMW   
Purchased over 20 shares of
few hours ago
Traded for 144.04
NBEV   
Purchased over 400 shares of
few hours ago
Traded for 7.39
Additionally take a look at Your Equity Center. Please also try Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Search macroaxis.com